Literature DB >> 22141409

Standardized comparison of prostate morcellators using a new ex-vivo model.

Manuel Ritter1, Patrick Krombach, Christian Bolenz, Andreas Martinschek, Thorsten Bach, Axel Haecker.   

Abstract

BACKGROUND AND
PURPOSE: Transurethral laser enucleation of the prostate is a common therapeutic option for the treatment of benign prostate enlargement. Evacuation of the enucleated tissue from the bladder is usually performed by electric morcellators. Until now, a standardized evaluation of the different morcellator settings does not exist. Therefore, we developed an ex-vivo model to find the best settings for four different morcellators.
MATERIALS AND METHODS: We morcellated pieces of a prostate adenoma after an open adenomectomy. The same speed settings were used to morcellate commercially available minced meat, fine pork sausage meat, and bovine heart, all of which had been cooked for 10 minutes using a Piranha Morcellator. We also morcellated raw pig perirenal fat tissue, raw pig liver, and raw bovine heart. The pieces were morcellated at different speed settings in an open water tank filled with saline. Because raw bovine heart showed to be the most equivalent tissue, we morcellated five pieces with four different settings of four different morcellators: The Piranha, the VersaCut, and two morcellator prototypes.
RESULTS: The median retrieval rate for the prostate adenoma was 14.02 (3.7-19.8) g/min. The retrieval rate for raw bovine heart was 13.75 (5.66-20) g/min. The maximum morcellation rates of the morcellators were: Piranha 20 (19.3-21.4) g/min, VersaCut 10.8 (8.2-13.1) g/min, Karl Storz prototype 9.8 (7.9-10.76) g/min, and Richard Wolf prototype 38.6 (35.3-42.9) g/min.
CONCLUSION: Raw bovine heart tissue is suitable for ex-vivo testing of prostate morcellators and can replace human prostate tissue in this standardized setting. In our ex-vivo study, the morcellation rates of the different morcellators increased with optimized oscillation speed and suction power settings. This needs to be confirmed in clinical studies.

Entities:  

Mesh:

Year:  2012        PMID: 22141409     DOI: 10.1089/end.2011.0536

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

1.  Towards optimizing prostate tissue retrieval following holmium laser enucleation of the prostate (HoLEP): Assessment of two morcellators and review of literature.

Authors:  Ahmed M Elshal; Ramy Mekkawy; Mahmoud Laymon; Ahmed El-Assmy; Ahmed R El-Nahas
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

Review 2.  In 2013, holmium laser enucleation of the prostate (HoLEP) may be the new 'gold standard'.

Authors:  Simon van Rij; Peter J Gilling
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

3.  Clinical and Pathological Characteristics of Hard Nodules Resistant to Morcellation During Holmium Laser Enucleation of the Prostate.

Authors:  Songzhe Piao; Min Soo Choo; Yue Wang; Young Ju Lee; Jungbum Bae; Seung-June Oh
Journal:  Int Neurourol J       Date:  2015-06-29       Impact factor: 2.835

4.  Holmium laser enucleation of the prostate: surgical, functional, and quality-of-life outcomes upon extended follow-up.

Authors:  Ilter Alkan; Hakan Ozveri; Yigit Akin; Tumay Ipekci; Yusuf Alican
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.